The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. SpringWorks Therapeutics Inc shares valued at $1,988,033 were sold by Islam Saqib on Sep 03 ’24. At $40.57 per share, Islam Saqib sold 49,000 shares. The insider’s holdings dropped to 1,063,368 shares worth approximately $38.6 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Edris Badreddin sold 20,000 shares, netting a total of over 812,954 in proceeds. Following the sale of shares at $40.65 each, the insider now holds 229,600 shares.
Before that, Badreddin Edris had added 50,000 shares to its account. In a trade valued at $2,089,000, the Officer bought SpringWorks Therapeutics Inc shares for $41.78 each.
As published in their initiating research note from Evercore ISI on November 20, 2024, SpringWorks Therapeutics Inc [SWTX] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early February. As of December 01, 2022, BofA Securities has initiated its “Buy” rating for SWTX. Earlier on January 19, 2021, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for SWTX stock.
Analyzing SWTX Stock Performance
During the last five days, there has been a drop of approximately -0.68%. Over the course of the year, SpringWorks Therapeutics Inc shares have dropped approximately -0.55%. Shares of the company reached a 52-week high of $53.92 on 03/08/24 and a 52-week low of $28.21 on 10/24/24. A 50-day SMA is recorded $32.57, while a 200-day SMA reached $39.97. Nevertheless, trading volume fell to 1.48 million shares from 1.18 million shares the previous day.
Support And Resistance Levels for SpringWorks Therapeutics Inc (SWTX)
According to the 24-hour chart, there is a support level at 35.77, which, if violated, would cause prices to drop to 35.24. In the upper region, resistance lies at 37.19. The next price resistance is at 38.08. RSI (Relative Strength Index) is 60.70 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.71, which suggests the price will increase in the coming days. Percent R is at 25.19%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of SpringWorks Therapeutics Inc (SWTX)?
On October 29, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $73.
